Friday, September 18, 2020

Cuba is working on a vaccine to combat COVID-19

Must Read

Road To 3rd Republic: Halifa Explains Procedures Undertaken By CRC To Chart The Way Forward

By Momodou Jarju The national assembly member for Serrekunda has used part of his debate-time on The Gambia Promulgation Bill...

RE: President Adama Barrow Relaxes Nightly Curfew and Market Restrictions, Public Health Regulations Remain In Force

At the expiration of the State of Public Emergency by midnight tonight, His Excellency, President Adama Barrow, has decided...

33 New Cases of COVID-19 Registered, No New Death

By Nelson Manneh The Gambia has registered thirty-three new cases of the deadly Coronavirus, taking the total number of COVID-19...

Havana, Apr 15 (RHC) Cuba is conducting a clinical trial for a vaccine developed with its own technology and aimed at activating the innate immune system to combat the new coronavirus SARS Cov-2, which causes COVID-19.

During a Round Table TV program aired Monday dedicated to Cuban biotechnology, Gerardo Guillén, research director of the Center for Genetic Engineering and Biotechnology (CIGB), explained that the drug called CIGB 2020 is undergoing clinical trials at the Luis Díaz Soto Hospital in Havana.

The trial involves volunteer patients suspected of being carriers of the disease, highlighted the Cuban National News Agency.

Guillen added that it is applied nasally, and sublingually and encouraging results have already been observed regarding the activation of the innate immune system, which is very important for successfully combating this disease.

We have seen how the molecules on the cell surface that mark the innate immune system related to viruses are stimulated fundamentally, and we also see at the blood level that lymphocytes and other chromatographs that are in charge of presenting the antigens to the coronavirus are being stimulated, the researcher explained.

- Advertisement -

He added that the CIGB 2020 is a medicine that is inserted, together with another Cuban vaccine developed by the Finlay Institute, in a field of research that is much debated in contemporary science, which is the development of specific vaccines to stimulate innate immunity, which is driven by the new coronavirus.

Our researchers have been able to make the laboratory technologies available to this research in record time. After these first results, we will continue with the trials and analyzing the results, said Guillén.

Latest News

Road To 3rd Republic: Halifa Explains Procedures Undertaken By CRC To Chart The Way Forward

By Momodou Jarju The national assembly member for Serrekunda has used part of his debate-time on The Gambia Promulgation Bill...
- Advertisement -

RE: President Adama Barrow Relaxes Nightly Curfew and Market Restrictions, Public Health Regulations Remain In Force

At the expiration of the State of Public Emergency by midnight tonight, His Excellency, President Adama Barrow, has decided to relax the night curfew...

33 New Cases of COVID-19 Registered, No New Death

By Nelson Manneh The Gambia has registered thirty-three new cases of the deadly Coronavirus, taking the total number of COVID-19 cases ever confirmed in the...

SoNA 2020: Barrow Assures Gambians General Elections Will Be Conducted in 2021

By Momodou Jarju President Adama Barrow has assured Gambians that his-led administration is committed to the conducting of the 2021 general elections. He said this while...

What Did Speaker Denton tells the National Assembly members on the impasse regarding media coverage of the sittings?

In her opening remarks, the Speaker indicated that she would like to inform the members the issue raised by the member for Serrekunda regarding...
- Advertisement -

People Also Read This